NT-pro-BNP Level is Related to Left Ventricular Remodeling in Patients With Primary Aldosteronism

Abstract

Aims To assess the relationship between the left ventricular remodeling parameters of cardiac magnetic resonance and NT-pro-BNP in patients with primary aldosteronism (PA).

Methods Seventy-four PA and 39 essential hypertension patients were prospectively recruited and underwent cardiac magnetic resonance. Plasma NT-pro-BNP was measured before patients underwent cardiac magnetic resonance. Left ventricular remodeling parameters were defined as left ventricular function parameters, T1 mapping parameters, and strain parameters. Differences in continuous variables between two groups were analyzed using Student’s t-test or Mann–Whitney U test. Differences in categorical variables between two groups were analyzed by chi-squared test. Spearman’s correlation and linear regression were used to analyze the relationships between left ventricular remodeling parameters and plasma NT-Pro-BNP level. P<0.05 was considered as statistically significant.

Results Patients with PA demonstrated higher NT-pro-BNP [86.0 (49.5, 145.5) vs. 45.0 (28.5, 73.5) pg/mL, P=0.001] and Native T1 (1227±41 vs. 1206±43 ms, P=0.015) level than essential hypertension patients. Compared to patients with normal NT-pro-BNP levels, those with abnormal levels demonstrated different left ventricular remodeling parameters. NT-pro-BNP level was independently related to native T1 (β=0.316, P=0.006), extracellular volume (β=0.419, P<0.001), short-axis global circumferential strain (β=0.429, P<0.001), four-chamber global longitudinal strain (β=0.332, P=0.002), and four-chamber global radial strain (β=-0.334, P=0.004) in patients after adjusting for baseline characteristics.

Conclusions NT-pro-BNP level was related to left ventricular remodeling parameters derived from cardiac magnetic resonance in patients with PA. This result implies that clinicians should pay attention to NT-pro-BNP assessment in patients with PA in routine clinical assessment.

Keywords

primary aldosteronism - cardiac magnetic resonance imaging - NT-pro-BNP - left ventricular remodeling

Publication History

Received: 08 March 2024
Received: 01 May 2024

Accepted: 03 June 2024

Article published online:
02 September 2024

• References

• 1 Reincke M, Bancos I, Mulatero P. et al. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol 2021; 9: 876-892
• 2 Zennaro MC, Boulkroun S, Fernandes-Rosa FL. Pathogenesis and treatment of primary aldosteronism. Nat Rev Endocrinol 2020; 16: 578-589
• 3 Cesari M, Letizia C, Angeli P. et al. Cardiac remodeling in patients with primary and secondary aldosteronism: A tissue Doppler study. Circ Cardiovasc Imaging 2016; 9
• 4 Bière L, Donal E, Jacquier A. et al. A new look at left ventricular remodeling definition by cardiac imaging. Int J Cardiol 2016; 209: 17-19
• 5 Wu T, Ren Y, Wang W. et al. Left Ventricular remodeling in patients with primary aldosteronism: A prospective cardiac magnetic resonance imaging study. Korean J Radiol 2021; 22: 1619-1627
• 6 Tsai CH, Pan CT, Chang YY. et al. Left ventricular remodeling and dysfunction in primary aldosteronism. J Hum Hypertens 2021; 35: 131-147
• 7 Rossi GP, Cesari M, Cuspidi C. et al. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Hypertension 2013; 62: 62-69
• 8 Gastl M, Behm P, Haberkorn S. et al. Role of T2 mapping in left ventricular reverse remodeling after TAVR. Int J Cardiol 2018; 266: 262-268
• 9 Nordin S, Dancy L, Moon JC. et al. Clinical applications of multiparametric CMR in left ventricular hypertrophy. Int J Cardiovasc Imaging 2018; 34: 577-585
• 10 Tian H, Cui J, Yang C. et al. Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation. BMC Cardiovasc Disord 2018; 18: 207
• 11 Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 2004; 6: 257-260
• 12 Whitman IR, Vittinghoff E, DeFilippi CR. et al. NT-pro BNP as a mediator of the racial difference in incident atrial fibrillation and heart failure. J Am Heart Assoc 2019; 8: e010868
• 13 Liu CY, Heckbert SR, Lai S. et al. Association of elevated NT-proBNP with myocardial fibrosis in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2017; 70: 3102-3109
• 14 Funder JW, Carey RM, Mantero F. et al. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101: 1889-1916
• 15 Yancy CW, Jessup M, Bozkurt B. et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 2017; 136: e137-e161
• 16 Kramer CM, Barkhausen J, Bucciarelli-Ducci C. et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson 2020; 22: 17
• 17 Meloni A, Righi R, Missere M. et al. Biventricular reference values by body surface area, age, and gender in a large cohort of well-treated thalassemia major patients without heart damage using a multiparametric CMR approach. J Magn Reson Imag 2021; 53: 61-70
• 18 Chen CA, Dusenbery SM, Valente AM. et al. Myocardial ECV fraction assessed by CMR is associated with type of hemodynamic load and arrhythmia in repaired tetralogy of fallot. JACC Cardiovasc Imag 2016; 9: 1-10
• 19 Goetze JP, Bruneau BG, Ramos HR. et al. Cardiac natriuretic peptides. Nat Rev Cardiol 2020; 17: 698-717
• 20 Wu L, Zhang L, Ai Z. et al. Association between risk factors and left ventricular remodeling in middle-aged and aged population: A community-based study. J Hypertens 2012; 30: 1862-1873
• 21 Breetveld NM, Alers RJ, Geerts L. et al. Low plasma volume and increased pressure load relate to concentric left ventricular remodeling after preeclampsia: A longitudinal study. J Am Heart Assoc 2020; 9: e015043
• 22 Chen C, Sung KT, Shih SC. et al. Age, Gender and load-related influences on left ventricular geometric remodeling, systolic mid-wall function, and NT-proBNP in asymptomatic Asian population. PloS One 2016; 11: e0156467
• 23 Januzzi JL, Prescott MF, Butler J. et al. Association of change in N-terminal pro-B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction. JAMA 2019; 322: 1085-1095
• 24 Desai AS, Solomon SD, Shah AM. et al. Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: A randomized clinical trial. JAMA 2019; 322: 1077-1084
• 25 Jakubik P, Janota T, Widimsky J. et al. Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration. Blood Press 2006; 15: 302-307
• 26 Kato J, Etoh T, Kitamura K. et al. Atrial and brain natriuretic peptides as markers of cardiac load and volume retention in primary aldosteronism. Am J Hypertens 2005; 18: 354-357
• 27 Zhang G, Shi K, Yan WF. et al. Effects of diabetes mellitus on left ventricular function and remodeling in hypertensive patients with heart failure with reduced ejection fraction: Assessment with 3.0 T MRI feature tracking. Cardiovasc Diabetol 2022; 21: 69
• 28 Kramer CM, Chandrashekhar Y, Narula J. The tissue issue: T1 mapping and the myocardium. JACC Cardiovascular Imaging 2016; 9: 88-90
• 29 Wei X, Jian X, Xie J. et al. T1 mapping and feature tracking imaging of left ventricular extracellular remodeling in severe aortic stenosis. Cardiovasc Diagn Ther 2020; 10: 1847-1857
• 30 Yang MX, He Y, Ma M. et al. Characterization of infarcted myocardium by T1-mapping and its association with left ventricular remodeling. Eur J Radiol 2021; 137: 109590
• 31 Rank N, Stoiber L, Nasser M. et al. Assessment of 10-year left-ventricular-remodeling by CMR in patients following aortic valve replacement. Front Cardiovasc Med 2021; 8: 645693
• 32 Reindl M, Tiller C, Holzknecht M. et al. Global longitudinal strain by feature tracking for optimized prediction of adverse remodeling after ST-elevation myocardial infarction. Clin Res Cardiol 2021; 110: 61-71